Top Vaccines companies in Sweden by Inventory
Sweden
# |
Name |
Inventory |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 382.36 M
|
Dec. 31, 2023 | USD 29.22 | -3.00% |
|
Sweden |
|
| 2 |
USD 66.55 M
|
Dec. 31, 2023 | USD 3.55 | -2.70% |
|
Sweden |
|
| 3 |
USD 11.52 M
|
Dec. 31, 2023 | USD 31.05 | 0.32% |
|
Sweden |
|
| 4 |
USD 1.47 M
|
Dec. 31, 2023 | USD 2.25 | -17.68% |
|
Sweden |
|
| 5 |
USD 1.17 M
|
Dec. 31, 2023 | USD 2.43 | -5.44% |
|
Sweden |
|
| 6 |
USD 1.13 M
|
Dec. 31, 2023 | USD 0.13 | 0.88% |
|
Sweden |
|
| 7 |
USD 702.25 K
|
Dec. 31, 2023 | USD 0.85 | -1.32% |
|
Sweden |
|
| 8 |
USD 0.09
|
Aug. 31, 2023 | USD 1.49 | -4.08% |
|
Sweden |
|
| 9 |
USD 0.00
|
Dec. 31, 2023 | USD 0.71 | 8.98% |
|
Sweden |
|
| 10 |
USD 0.00
|
Dec. 31, 2023 | USD 0.39 | -4.99% |
|
Sweden |
|
| 11 |
USD 0.00
|
Dec. 31, 2023 | USD 1.26 | -1.32% |
|
Sweden |
|
| 12 |
USD -22.01 K
|
Dec. 31, 2023 | USD 18.98 | -4.07% |
|
Sweden |
Frequently Asked Questions
-
Which Vaccines company in Sweden has the highest Inventory ?
The Vaccines company in Sweden with the highest Inventory is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 382.36 M.
-
Which Vaccines company in Sweden has the lowest Inventory ?
The Vaccines company in Sweden with the lowest Inventory is BioArctic AB (publ) (Stockholm Stock Exchange: BIOA-B.ST) at USD -22.01 K.
-
What are the top 10 Vaccines companies in Sweden by Inventory ?
The top 10 Vaccines companies in Sweden by Inventory are Swedish Orphan Biovitrum AB (publ), Vimian Group AB (publ), Probi AB (publ), Genovis AB (publ.), BioInvent International AB (publ), Enzymatica AB (publ), Moberg Pharma AB (publ), Diamyd Medical AB (publ), Mendus AB (publ) and Iconovo AB (publ).
-
What are the bottom 10 Vaccines companies in Sweden by Inventory ?
The bottom 10 Vaccines companies in Sweden by Inventory are BioArctic AB (publ), SynAct Pharma AB, Iconovo AB (publ), Mendus AB (publ), Diamyd Medical AB (publ), Moberg Pharma AB (publ), Enzymatica AB (publ), BioInvent International AB (publ), Genovis AB (publ.) and Probi AB (publ).
